ASJC Scopus subject areas
- Cardiology and Cardiovascular Medicine
Access to Document
Other files and links
Utility of High-Sensitivity Troponin Among Stable Patients With Chest Pain Undergoing Stress Imaging (from PROMISE). / Sharma, Abhinav; Januzzi, James L.; Suchindran, Sunil et al.In: American Journal of Cardiology, Vol. 158, 01.11.2021, p. 148-149.
Research output: Contribution to journal › Letter › peer-review
TY - JOUR
T1 - Utility of High-Sensitivity Troponin Among Stable Patients With Chest Pain Undergoing Stress Imaging (from PROMISE)
AU - Sharma, Abhinav
AU - Januzzi, James L.
AU - Suchindran, Sunil
AU - Coles, Adrian
AU - Hoffmann, Udo
AU - Ferencik, Maros
AU - Patel, Manesh R.
AU - Ginsburg, Geoffrey S.
AU - Douglas, Pamela S.
N1 - Funding Information: PROMISE was funded by grants R01HL098237 , R01HL098236 , R01HL98305 , and R01HL098235 from the National Heart, Lung, and Blood Institute (NHLBI) . The present analysis was funded by an unrestricted grant from Singulex . Funding Information: Sharma: research support from the Fonds de Researche Sante Quebec Junior 1 award, AHA Strategically Focused Research Network - Heart Failure (16SFRN30180010), Alberta Innovates Health Solution Clinician Scientist fellowship, the European Society of Cardiology (Young Investigator research grant), and Roche Diagnostics, Takeda, BMS-Pfizer and the Canadian Cardiovascular Society (Bayer Vascular award). Januzzi: grant support from Singulex, consulting income from Roche Diagnostics, Critical Diagnostics, Philips, and Novartis, and participates in clinical endpoint committees/data safety monitoring boards for Siemens, Abbvie, Pfizer, Amgen, Janssen, and Boehringer Ingelheim. Hoffmann: grants from HeartFlow and Kowa Pharmaceuticals. Ferencik: research grant from the AHA (Fellow to Faculty Award 13FTF16450001). Patel: research grants from AstraZeneca, Janssen, Bayer, NHLBI, Philips, and Heartflow, and serves on advisory boards for Janssen, AstraZeneca, and Bayer. Ginsburg: consultant or advisory board member Fabric Genomics, Konica Minolta, AbbVie; stock options from Predigen, MeTree&You, Fabric Genomics, and Origin Commercial Advisors; board of directors for Keystone Symposia, Global Genomic Medicine Collaborative, Predigen; royalties from Elsevier; research funding to his institution from Abbott, and 23andMe. Douglas: grant support from HeartFlow. The other authors have no conflicts of interest to disclose.
PY - 2021/11/1
Y1 - 2021/11/1
UR - http://www.scopus.com/inward/record.url?scp=85114731395&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85114731395&partnerID=8YFLogxK
U2 - 10.1016/j.amjcard.2021.07.032
DO - 10.1016/j.amjcard.2021.07.032
M3 - Letter
C2 - 34454709
AN - SCOPUS:85114731395
VL - 158
SP - 148
EP - 149
JO - American Journal of Cardiology
JF - American Journal of Cardiology
SN - 0002-9149